NMR spectroscopy techniques

Events, Molecular Targets and Therapeutics, STB,

Biomolecular Breathing and the 4D View of Life: Insights from the BNMRZ Symposium

How do biomolecules breathe? This question guided the recent international symposium “Ultra-Highfield NMR and 4D Structural Biology – From Mechanisms to Therapies”, hosted by the Bavarian NMR Center (BNMRZ), a joint infrastructure of Helmholtz Munich…

HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, STB,

New Switch for Natural Cell Death Identified

In the fight against disease, programmed cell death – also known as apoptosis – is a key protective function of the body. It breaks down cells that are damaged or have undergone dangerous changes. However, cancer cells often manage to override this…

PURA Spendenübergabe

Molecular Targets and Therapeutics, STB,

PURA Syndrome Deutschland Makes Donation to Support Research at Helmholtz Munich

PURA Syndrome Deutschland e.V., a patient organization supporting families affected by the rare neurodevelopmental disorder PURA syndrome, has donated 10,000 Euros to Prof. Dierk Niessing’s research group at the Institute of Structural Biology at…

An NMR (Nuclear Magnetic Resonance) spectrometer in operation, with a scientist preparing a sample for molecular structure analysis

Molecular Targets and Therapeutics, STB,

Helmholtz Munich Joins Germany’s Instruct-ERIC Centre for Structural Biology

The Bavarian NMR Center (BNMRZ), a joint research infrastructure of Helmholtz Munich and the Technical University of Munich (TUM), has joined the newly established German Centre of Instruct-ERIC. This represents a significant advancement in expanding…

Quadratisches Format - ERC Logo

Awards & Grants, IES, LHI, Computational Health, AIH, Molecular Targets and Therapeutics, VIRO, STB,

Five ERC Starting Grants for Helmholtz Munich

Five prestigious Starting Grants from the European Research Council have been granted to researchers with Helmholtz Munich as the host institution. The funding will enable scientists at Helmholtz Munich to advance innovative projects across various…

Michael Sattler

Molecular Targets and Therapeutics, STB,

Unlocking the Future of Personalized Medicine

Prof. Michael Sattler on exploring the impact of understanding molecular disease mechanisms and advancing personalized therapies.